United HealthCare Community Plan of Arizona policies, page 4

Search United HealthCare Community Plan of Arizona's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

386 public policies Substrate tracks for United HealthCare Community Plan of Arizona, by title.

United HealthCare Community Plan of Arizona policies
PolicyDetailsCodesSource
Home Health, Skilled, and Custodial Care ServicesCS137.X · Effective Jul 1, 2026 · Medicaid140Original policy ↗
Home Traction TherapyCS058.Q · Effective May 1, 2026 · Medicaid8Original policy ↗
Homocysteine Testing for Metabolism Policy, Professional and FacilityEffective Jul 1, 2026 · Medicaid—Original policy ↗
Hospital Inclusive Charges Policy, Facility2026FR7134E · Effective Jan 23, 2024 · Medicaid8Original policy ↗
Hospital Services: Observation and InpatientCS356.E · Effective Sep 1, 2026 · Medicaid—Original policy ↗
HysterectomyCS196.I · Effective Feb 1, 2026 · Medicaid24Original policy ↗
Ilaris® (Canakinumab) – Community Plan Medical Benefit Drug PolicyMedicaid1Original policy ↗
Ilumya® (Tildrakizumab-Asmn)Medicaid1Original policy ↗
Immune Cell Function Assay Policy, Professional and FacilityEffective May 1, 2026 · Medicaid—Original policy ↗
Immune Globulin (IVIG and SCIG)Medicaid21Original policy ↗
Implantable Loop Recorders and Wearable Heart Rhythm MonitorsMedicaid11Original policy ↗
Implanted Electrical Stimulator for the Spinal CordCS061.AB · Effective Feb 1, 2026 · Medicaid12Original policy ↗
In Vitro Chemotherapy Assays, Professional and FacilityEffective Apr 28, 2026 · Medicaid—Original policy ↗
Incontinence Supplies Policy, ProfessionalMedicaid27Original policy ↗
Increased Procedural Services Policy, ProfessionalMedicaid32Original policy ↗
Infliximab – Community Plan Medical Benefit Drug PolicyMedicaid4Original policy ↗
Inhaled Nitric Oxide TherapyMedicaid1Original policy ↗
Injectable Dermal Fillers and Bulking AgentsCS371.C · Effective Jan 1, 2026 · Medicaid7Original policy ↗
Injection and Infusion Services Policy, ProfessionalMedicaid81Original policy ↗
Injections into the Tendon Sheath and Ligament, Ganglion Cyst, Carpal and Tarsal Tunnel Policy, ProfessionalMedicaid4Original policy ↗
Intensity Modulated Radiation Therapy Policy2026R0130A · Medicaid3Original policy ↗
Intensity-Modulated Radiation TherapyCS064.T · Effective May 1, 2026 · Medicaid9Original policy ↗
Interspinous Fusion and Decompression DevicesCS363.D · Effective Jan 1, 2026 · Medicaid8Original policy ↗
Intestinal Dysbiosis and Fecal Microbiota Transplant Testing Policy, Professional and FacilityEffective Sep 25, 2026 · Medicaid7Original policy ↗
Intracanalicular and Intravitreal Corticosteroid ImplantsMedicaid4Original policy ↗
Intracellular Micronutrient Analysis Policy, Professional and FacilityEffective May 1, 2026 · Medicaid4Original policy ↗
Intraoperative Neuromonitoring Policy, ProfessionalMedicaid32Original policy ↗
Intravenous Enzyme Replacement Therapy (ERT) for Gaucher DiseaseMedicaid3Original policy ↗
Intravenous Iron Replacement Therapy (Feraheme®, Injectafer®, & Monoferric®)Medicaid4Original policy ↗
Iron Homeostasis and Metabolism Policy, Professional and FacilityEffective Feb 1, 2026 · Medicaid—Original policy ↗
Itvisma® (Onasemnogene Abeparvovec-Brve)CS2026D0142C · Effective Sep 1, 2026 · Medicaid1Original policy ↗
Kebilidi® (Eladocagene Exuparvovec-Tneq)Medicaid2Original policy ↗
Ketalar® (Ketamine) and Spravato® (Esketamine)Medicaid2Original policy ↗
Korsuva® (Difelikefalin)Medicaid1Original policy ↗
Krystexxa® (Pegloticase)Medicaid1Original policy ↗
Laboratory Services Policy, Professional-Reimbursement Policy - UnitedHealthcare Community PlanMedicaid78Original policy ↗
Leqvio® (Inclisiran)Medicaid1Original policy ↗
Light and Laser TherapyCS069.T · Effective Feb 1, 2026 · Medicaid6Original policy ↗
Liposuction for LipedemaCS203.G · Effective Jan 1, 2026 · Medicaid3Original policy ↗
Long-Acting Injectable Antiretroviral Agents for HIVMedicaid4Original policy ↗
Lower Extremity Endovascular ProceduresCS166.P · Effective Jun 1, 2026 · Medicaid48Original policy ↗
Lower Extremity ProstheticsCS361.H · Effective Aug 1, 2026 · Medicaid204Original policy ↗
Luxturna® (Voretigene Neparvovec-Rzyl)Medicaid1Original policy ↗
Lyme Disease Testing Policy, Professional and FacilityMedicaid7Original policy ↗
Mandatory Medicaid Coverage of Routine Patient Costs in Qualifying Clinical TrialsMedicaid10Original policy ↗
Manipulative TherapyCS076.P · Effective Jun 1, 2026 · Medicaid11Original policy ↗
Maximum Dosage and Frequency – Community Plan Medical Benefit Drug PolicyCS2026D0034AV · Effective Aug 1, 2026 · Medicaid129Original policy ↗
Maximum Frequency Per Day Policy, ProfessionalMedicaid437Original policy ↗
Mechanical Stretching DevicesMedicaid30Original policy ↗
Medical Therapies for Enzyme DeficienciesCS2026D0052AG · Effective Apr 1, 2026 · Medicaid15Original policy ↗

Back to United HealthCare Community Plan of Arizona

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.